TNFα release by the nonfat cells of human adipose tissue

International Journal of Obesity

Volumn 28, Issue 4, 2004, Pages 616-622

  Fain, J N ^a   Bahouth, S W ^a   Madan, A K ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Adiponectin; HGF; IL 6; Leptin; Lipopolysaccharride; Niflumic acid; PAI 1

Indexed keywords

ADIPONECTIN; COLLAGENASE; CYCLOOXYGENASE 2 INHIBITOR; LEPTIN; LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; PROTEIN; SIGNAL PEPTIDE;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BODY MASS; CELL CULTURE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CULTURE MEDIUM; DIGESTION; DONOR; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INCUBATION TIME; PRIORITY JOURNAL; UPREGULATION; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; OBESITY; SUBCUTANEOUS TISSUE;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; BODY MASS INDEX; CULTURE TECHNIQUES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OBESITY; PROTEINS; SUBCUTANEOUS TISSUE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042670090     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802594     Document Type: Article

References (35)

1. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest; 1995; 95: 2409-2415.
2. Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Opposite regulation of plasma interleukin-8 and tumor necrosis factor-α by weight loss. Obes Res; 2002; 10: 499-506.
3. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor-a in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab; 1998; 83: 2907-2910.
4. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes Relat Metab Disord; 2000; 24: 1392-1395.
5. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, Patsch JR. Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord; 2002; 26: 659-662.
6. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol; 1999; 19: 972-978.
7. Berberoglu M. Evaluation of the correlation between serum tumor necrosis factor-alpha and relative body mass index (RBMI) in childhood. J Pediatr Endocrinol Metab; 2001; 14: 543-547.
8. Pincelli AI, Brunani A, Scacchi M, Dubini A, Borsotti R, Tibaldi A, Pasqualinotto L, Maestri E, Cavagnini F. The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone-or obesity-induced insulin resistance. Horm Res; 2001; 55: 57-64.
9. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab; 2001; 280: E745-E751.
10. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest; 1995; 95: 2111-2119.
11. Bullo M, Garcia-Lorda P, Peinado-Onsurbe J, Hernandez M, Castillo DD, Argiles JM, Salas-Salvado J. TNFα expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int J Obes Relat Metab Disord; 2002; 26: 652-658.
12. Mohamed-Ali V, Goodrick S, Bulmer K, Holly JM, Yudkin JS, Coppack SW. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol; 1999; 277: E971-E975.
13. Lofgren P, van Harmelen V, Reynisdottir S, Naslund E, Ryden M, Rossner S, Arner P. Secretion of tumor necrosis factor-α shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. Diabetes; 2000; 49: 688-692.
14. Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S. Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol; 1999; 163: 33-38.
15. McTernan PG, Harte AL, Anderson LA, Green A, Smith SA, Holder JC, Barnett AH, Eggo MC, Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes; 2002; 51: 1493-1498.
16. Gesta S, Lolmede K, Daviaud D, Berlan M, Bouloumie A, Lafontan M, Valet P, Saulnier-Blache JS. Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res; 2003; 35: 158-163.
17. Hotamisligil, GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science; 1993; 259: 87-91.
18. Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem; 1988; 47: 505-518.
19. Diez JJ, Iglesias P. The role of the novel adipocytes-derived hormone adiponectin in human disease. Eur J Endocrinol; 2003; 148: 293-300.
20. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol; 2002; 147: 173-180.
21. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA; 2003; 289: 1799-1804.
22. Kern PA, Di Gregorio BB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue; relation to obesity, insulin resistance and tumor necrosis factor-α expression. Diabetes; 2003; 52: 1779-1854.
23. Fawcett RL, Waechter AS, Williams LB, Zhang P, Louie R, Jones R, Inman M, Huse J, Considine RV. Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans. J Clin Endocrinol Metab; 2000; 85: 530-535.
24. Gottschling-Zeller H, Birgel M, Scriba D, Blum WF, Hauner H. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur J Endocrinol; 1999; 141: 436-442.
25. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev; 2003; 14: 447-455.
26. Dusserre E, Moulin P, Vidai H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta; 2000; 1500: 88-96.
27. Fain JN, Cheema PS, Bahouth SW, Hiler ML. Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun; 2003; 300: 674-678.
28. Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA. Mechanisms regulating adipocyte expression of resistin. J Biol Chem; 2002; 277: 19754-19761.
29. Kim K-H, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem; 2001; 276: 11252-11256.
30. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun; 2001; 285: 561-564.
31. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes; 2001; 50: 2199-2202.
32. Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes; 2002; 51: 1876-1883.
33. Viviani B, Corsini E, Pesenti M, Galli CL, Marinovich M. Trimethyltin-activated cyclooxygenase stimulates tumor necrosis factor-alpha release from glial cells through reactive oxygen species. Toxicol Appl Pharmacol; 2001; 172: 93-97.
34. Fennekohl A, Sugimoto Y, Segi E, Maruyama T, Ichikawa A, Puschel GP. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells. J Hepatol; 2002; 36: 328-334.
35. Dooper MM, Wassink L, M'Rabe L, Graus YM. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology; 2002; 107: 152-159.